Takeda Taps Twist Bioscience to Boost Biologics Discovery Capabilities

Takeda Taps Twist Bioscience to Boost Biologics Discovery Capabilities

Source: 
BioSpace
snippet: 

Shares of Twist Bioscience jumped nearly 10% in Wednesday morning trading after the company forged an agreement with Takeda Pharmaceutical to expand biologics discovery capabilities and discover, validate and optimize new antibody candidates for a number of different indications.